房颤患者不良结局事件的性别差异
本研究基于两项相似的前瞻性多中心队列,随访3894例(28%女性)既往确诊房颤患者中位4.02年。女性主要复合终点(缺血性卒中、心肌梗死和心血管死亡)发生率低于男性(aHR 0.74),心血管与非心血管死亡风险均较低,但卒中、心肌梗死、出血及心衰住院无显著性别差异。
要点
- 女性房颤患者主要复合终点风险低于男性(aHR 0.74)。
- 女性心血管死亡(aHR 0.57)和非心血管死亡(aHR 0.68)风险均较低。
- 卒中、心肌梗死、出血及心衰住院无显著性别差异。
核心结论
- 在已确诊房颤患者中,女性死亡风险低于男性,但其他不良结局无显著性别差异。
研究设计与样本
- 两项相似的前瞻性观察性多中心队列研究,纳入3894例(28%女性)既往确诊房颤患者,中位随访4.02(3.00-5.83)年。
主要发现
- 女性平均年龄73.1岁,男性70.8岁。
- 主要复合终点(缺血性卒中、心肌梗死和心血管死亡)女性 vs 男性发生率为2.46 vs 3.24/100患者年(aHR 0.74,95%CI 0.58-0.94;p=0.01)。
- 心血管死亡aHR 0.57(95%CI 0.41-0.78;p<0.001),非心血管死亡aHR 0.68(95%CI 0.47-0.98;p=0.04)。
- 卒中(发生率1.05 vs 1.00;aHR 1.02,95%CI 0.70-1.49;p=0.93)、心肌梗死(0.67 vs 0.72;aHR 0.98,95%CI 0.61-1.57;p=0.94)、大出血及临床相关非大出血(4.51 vs 4.34;aHR 0.95,95%CI 0.79-1.15;p=0.63)、心衰住院(3.28 vs 3.07;aHR 1.06,95%CI 0.85-1.32;p=0.60)均无显著性别差异。
临床怎么用
- 女性房颤患者死亡风险较低,但卒中、出血等风险与男性相当,抗凝等管理策略应基于风险评分而非性别。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess whether women with atrial fibrillation (AF) have a higher risk of adverse events than men during long-term follow-up since controversial data have been published. METHODS: In the context of two very similar observational multicentre cohort studies, we prospectively followed 3894 patients (28% women) with previously documented AF for a median of 4.02 (3.00-5.83) years. The primary outcome was a composite of ischaemic stroke, myocardial infarction and cardiovascular death. Secondary outcomes included the individual components of the composite outcome, hospitalisation for heart failure, major and clinically relevant non-major bleeding, stroke or systemic embolism and non-cardiovascular death. RESULTS: Mean age was 73.1 years in women vs 70.8 years in men. The incidence of the primary endpoint in women versus men was 2.46 vs 3.24 per 100 patient-years, respectively (adjusted HR (aHR) 0.74, 95% CI 0.58 to 0.94; p=0.01). Women died less frequently from cardiovascular (aHR 0.57, 95% CI 0.41 to 0.78; p<0.001) and non-cardiovascular causes (aHR 0.68, 95% CI 0.47 to 0.98; p=0.04). There were no significant sex-specific differences in stroke (incidence 1.05 vs 1.00; aHR 1.02, 95% CI 0.70 to 1.49, p=0.93), myocardial infarction (incidence 0.67 vs 0.72; aHR 0.98, 95% CI 0.61 to 1.57, p=0.94), major and clinically relevant non-major bleeding (incidence 4.51 vs 4.34; aHR 0.95, 95% CI 0.79 to 1.15, p=0.63) or heart failure hospitalisation (incidence 3.28 vs 3.07; aHR 1.06, 95% CI 0.85 to 1.32, p=0.60). CONCLUSION: In this large study of patients with established AF, women had a lower risk of death than men, but there were no sex-specific differences in other adverse outcomes.
引用
- Evers-Dörpfeld, Aeschbacher, Hennings, et al. Sex-specific differences in adverse outcome events among patients with atrial fibrillation. Heart. 2022. PMID: 35135836. doi:10.1136/heartjnl-2021-320122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。